Curaleaf Holdings (CURLF) Net Margin (2019 - 2026)
Curaleaf Holdings (CURLF) recorded quarterly Net Margin of 0.09% in Q1 2026, up 100.0% quarter-over-quarter from 2484777.88% in Q4 2025, and up 323.0% on a YoY basis from 0.02% in Q1 2025.
Curaleaf Holdings (CURLF) Net Margin (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Net Margin history runs 8 years deep, the most recent figure standing at 0.09% for Q1 2026.
- In Q1 2026, Net Margin rose 323.0% year-over-year to 0.09%; the TTM figure through Mar 2026 stood at 1748.88% (down 174726.0% YoY), while the FY2025 annual figure was 2.07%, down 129.0% from the prior year.
- Net Margin was 0.09% for Q1 2026 at Curaleaf Holdings, up from 2484777.88% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 6.86% in Q1 2022 to a low of 2484777.88% in Q4 2025.
- Historically, Net Margin has averaged 359719.4% across 5 years, with a median of 2.84% in 2023.
- The sharpest annual moves came in 2024 and 2025: Net Margin soared 231558231 bps in 2024, then tumbled 248477438 bps in 2025.
- A 5-year view of Net Margin shows it stood at 24.58% in 2022, then sank by 9418984 bps to 2315585.82% in 2023, then surged by 100 bps to 3.51% in 2024, then sank by 70876058 bps to 2484777.88% in 2025, then soared by 100 bps to 0.09% in 2026.
- The last three Net Margin figures came in at 0.09% (Q1 2026), 2484777.88% (Q4 2025), and 0.67% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 9.19% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 26.57% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 35.18% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 2.94% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 24.30% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 4.16% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -168.42% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 31.38% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -15.15% |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | -0.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.09% |
| Dec 31, 2025 | -2,484,777.88% |
| Sep 30, 2025 | -0.67% |
| Jun 30, 2025 | -955,106.19% |
| Mar 31, 2025 | -3.32% |
| Dec 31, 2024 | -3.51% |
| Sep 30, 2024 | 0.49% |
| Jun 30, 2024 | -0.37% |
| Mar 31, 2024 | 0.17% |
| Dec 31, 2023 | -2,315,585.82% |
| Sep 30, 2023 | -7.78% |
| Jun 30, 2023 | -2.36% |
| Dec 31, 2022 | -24.58% |
| Sep 30, 2022 | -3.92% |
| Jun 30, 2022 | -1.38% |
| Mar 31, 2022 | 6.86% |
| Dec 31, 2021 | -1.70% |
| Sep 30, 2021 | 19.98% |
| Jun 30, 2021 | 24.78% |
| Mar 31, 2021 | 17.93% |